Stay updated on LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T23:52:47.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added. The funding-lapse notice and the prior Revision: v3.4.1 have been removed.
    Difference
    0.4%
    Check dated 2026-02-11T14:09:26.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and the NIH Clinical Center's status was added, with guidance to refer to opm.gov for updates; the page revision label was updated from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:21:42.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Glossary toggle added; capitalization adjusted for labels (e.g., ‘Last Update Submitted that Met QC Criteria’ and ‘No FEAR Act Data’); revision updated to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T06:13:59.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed; the visible trial details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:01:25.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Locations section updated: site listings were adjusted (Georgia, New York, North Carolina, Ohio, Texas, North Holland, South Holland) and the page revision updated from v3.3.2 to v3.3.3.
    Difference
    0.8%
    Check dated 2025-12-23T17:09:47.000Z thumbnail image

Stay in the know with updates to LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page.